Literature DB >> 25082570

Pre-filled syringe - a ready-to-use drug delivery system: a review.

Rahul G Ingle1, Aayush S Agarwal.   

Abstract

INTRODUCTION: Fueled by a growing global expectation of the health and medical fields, billions of dollars/euros/pounds are invested every year in the research of new biological and chemical entities. However, little interest is seen in the development of novel drug delivery systems. One such system, pre-filled syringe (PFS), was invented decades ago but is still a rare mode of delivery in many therapeutic segments. AREAS COVERED: This review comprises properties and effects of extractables, leachables and discuss the characteristics of PFS technology; its composition, glass and polymer types, configuration of PFS, advantages over glass, technical and commercial applicability; its significance against patient, industry, quality, environment and cost; and its business potential. We discuss in brief about PFS used in various major and life-threatening disorders and future prospects. It provides showers of knowledge in the field of PFS drug delivery technology to the reader's, industrialist's and researcher's point of view. EXPERT OPINION: The PFS drug delivery system offers a wonderful panorama to lifesaving drugs that are currently only available in conventional vials and ampoules in the market. A novel approach of Form Fill Seal technology can be adopted for this particular ready-to-use dosage form also, which opens the new global doors for budding researchers in the field of pre-filled drug delivery system.

Entities:  

Keywords:  business; drug delivery; extractables; leachables; needlestick injury; pre-filled syringe

Mesh:

Substances:

Year:  2014        PMID: 25082570     DOI: 10.1517/17425247.2014.923400

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  2 in total

Review 1.  US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives.

Authors:  Shawn Shouye Wang; Yifei Susie Yan; Kin Ho
Journal:  Antib Ther       Date:  2021-11-18

2.  Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Sheryl S Siegmund; Jay DePasse; Jennifer Bakal; Jim Leonard; Joel Welling; Shawn T Brown; Bruce Y Lee
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.